Kevin Marsh

3.6k total citations · 2 hit papers
79 papers, 2.3k citations indexed

About

Kevin Marsh is a scholar working on Economics and Econometrics, General Health Professions and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Kevin Marsh has authored 79 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Economics and Econometrics, 15 papers in General Health Professions and 13 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Kevin Marsh's work include Health Systems, Economic Evaluations, Quality of Life (32 papers), Economic and Environmental Valuation (17 papers) and Pharmaceutical Economics and Policy (7 papers). Kevin Marsh is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (32 papers), Economic and Environmental Valuation (17 papers) and Pharmaceutical Economics and Policy (7 papers). Kevin Marsh collaborates with scholars based in United Kingdom, United States and Netherlands. Kevin Marsh's co-authors include Praveen Thokala, Rob Baltussen, Filip Mussen, Nancy Devlin, John B. Watkins, Zoltán Kaló, Maarten J. IJzerman, Stuart Peacock, Meindert Boysen and J. Jaime and has published in prestigious journals such as The Lancet, Blood and PLoS ONE.

In The Last Decade

Kevin Marsh

73 papers receiving 2.2k citations

Hit Papers

Multiple Criteria Decision Analysis for Health Care Decis... 2016 2026 2019 2022 2016 2016 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Multiple Criteria Decision Analysis for Health Care Decision Making—An Introduction: Report 1 of the ISPOR MCDA Emerging Good Practices Task Force
    2016 444 citations Praveen Thokala, Nancy Devlin et al. Value in Health profile →
  2. Multiple Criteria Decision Analysis for Health Care Decision Making—Emerging Good Practices: Report 2 of the ISPOR MCDA Emerging Good Practices Task Force
    2016 301 citations Kevin Marsh, Maarten J. IJzerman et al. Value in Health profile →

Peers

Kevin Marsh
Praveen Thokala United Kingdom
Zoltán Kaló Hungary
J. Chilcott United Kingdom
Blanca Gallego Australia
Paul Tappenden United Kingdom
Rachael Fleurence United States
José Luis Pinto Prades Spain
Karen Facey United Kingdom
Tony Tse United States
Recai Yucel United States
Praveen Thokala United Kingdom
Kevin Marsh
Citations per year, relative to Kevin Marsh Kevin Marsh (= 1×) peers Praveen Thokala

Countries citing papers authored by Kevin Marsh

Since Specialization
Citations

This map shows the geographic impact of Kevin Marsh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevin Marsh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevin Marsh more than expected).

Fields of papers citing papers by Kevin Marsh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kevin Marsh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevin Marsh. The network helps show where Kevin Marsh may publish in the future.

Co-authorship network of co-authors of Kevin Marsh

This figure shows the co-authorship network connecting the top 25 collaborators of Kevin Marsh. A scholar is included among the top collaborators of Kevin Marsh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kevin Marsh. Kevin Marsh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Marsh, Kevin, et al.. (2024). Preferences of patients and physicians in the United States for relapsed/refractory follicular lymphoma treatments. Cancer Medicine. 13(19). e70177–e70177. 2 indexed citations
2.
Ashaye, Ajibade, Mehul Dalal, Vamsi Kota, et al.. (2022). Patient preferences for frontline therapies for Philadelphia chromosome-positive acute lymphoblastic leukemia: a discrete choice experiment. Future Oncology. 18(17). 2075–2085. 4 indexed citations
3.
Krucien, Nicolas, et al.. (2022). Preferences for Anaemia Treatment Attributes among Patients with Non-Dialysis-Dependent Chronic Kidney Disease. Advances in Therapy. 40(2). 641–657. 6 indexed citations
4.
5.
6.
Winner, Paul, Ann Hartry, Thomas Brevig, et al.. (2021). Patient Preference for Early Onset of Efficacy in Migraine Prevention (1749). Neurology. 96(15_supplement). 1 indexed citations
7.
Smith, Meredith Y., Janine A. van Til, Rachael L. DiSantostefano, Brett Hauber, & Kevin Marsh. (2020). Quantitative Benefit–Risk Assessment: State of the Practice Within Industry. Therapeutic Innovation & Regulatory Science. 55(2). 415–425. 18 indexed citations
8.
Pinto, Cathy Anne, Tommi Tervonen, Kevin Marsh, et al.. (2019). Personalized benefit‐risk assessments combining clinical trial and real‐world data provide further insights into which patients may benefit most from therapy: Demonstration for a new oral antiplatelet therapy. Pharmacoepidemiology and Drug Safety. 28(4). 443–451. 6 indexed citations
9.
Marsh, Kevin, Adrian Quartel, Haoling H. Weng, et al.. (2019). A benefit-risk analysis of pegvaliase for the treatment of phenylketonuria: A study of patients' preferences. Molecular Genetics and Metabolism Reports. 21. 100507–100507. 14 indexed citations
10.
Tervonen, Tommi, Heather L. Gelhorn, Jiat Ling Poon, et al.. (2017). MCDA swing weighting and discrete choice experiments for elicitation of patient benefit‐risk preferences: a critical assessment. Pharmacoepidemiology and Drug Safety. 26(12). 1483–1491. 46 indexed citations
11.
Thokala, Praveen, Nancy Devlin, Kevin Marsh, et al.. (2016). Multiple Criteria Decision Analysis for Health Care Decision Making—An Introduction: Report 1 of the ISPOR MCDA Emerging Good Practices Task Force. Value in Health. 19(1). 1–13. 444 indexed citations breakdown →
12.
Marsh, Kevin, et al.. (2016). Evaluation of COPD Treatments: A Multicriteria Decision Analysis of Aclidinium and Tiotropium in the United States. Value in Health. 20(1). 132–140. 15 indexed citations
13.
Marsh, Kevin, et al.. (2016). INCORPORATING ENVIRONMENTAL OUTCOMES INTO A HEALTH ECONOMIC MODEL. International Journal of Technology Assessment in Health Care. 32(6). 400–406. 34 indexed citations
14.
15.
Browne, Chantelle, N. Muszbek, Ruth Chapman, et al.. (2016). Comparative healthcare-associated costs of methicillin-resistant Staphylococcus aureus bacteraemia-infective endocarditis treated with either daptomycin or vancomycin. International Journal of Antimicrobial Agents. 47(5). 357–361. 10 indexed citations
16.
Lawson, Richard, et al.. (2014). How Does Non-Malignant Opioid Induced Constipation (Oic) Impact Health State Utility?. Value in Health. 17(7). A369–A369. 2 indexed citations
17.
Marsh, Kevin, Ruth Chapman, Rebecca F. Baggaley, Nathalie Largeron, & Xavier Bresse. (2014). Mind the gaps: What's missing from current economic evaluations of universal HPV vaccination?. Vaccine. 32(30). 3732–3739. 18 indexed citations
18.
Thokala, Praveen, et al.. (2014). Multi Criteria Decision Analysis Methods In Health Care: Current Status, Good Practice And Future Recommendations. Value in Health. 17(3). A34–A34. 2 indexed citations
19.
Cherry, Mary Gemma, J Greenhalgh, Leeza Osipenko, et al.. (2012). The clinical effectiveness and cost-effectiveness of primary stroke prevention in children with sickle cell disease: a systematic review and economic evaluation.. Health Technology Assessment. 16(43). 1–129. 34 indexed citations
20.
Phillips, Ceri, Richard Fordham, Kevin Marsh, et al.. (2010). Exploring the role of economics in prioritization in public health: what do stakeholders think?. European Journal of Public Health. 21(5). 578–584. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Praveen Thokala Breakdown of academic impact, for papers by Zoltán Kaló Breakdown of academic impact, for papers by J. Chilcott Breakdown of academic impact, for papers by Blanca Gallego Breakdown of academic impact, for papers by Paul Tappenden Breakdown of academic impact, for papers by Rachael Fleurence Breakdown of academic impact, for papers by José Luis Pinto Prades Breakdown of academic impact, for papers by Karen Facey Breakdown of academic impact, for papers by Tony Tse Breakdown of academic impact, for papers by Recai Yucel
Rankless by CCL
2026